PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

2-bromo-3,3,3-trifluoroprop-1-ene

EC / List no: 627-872-0 CAS no: 1514-82-5
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Comprehensive
Status
Concluded
Decision date
13-Dec-2019
Decision
Latest update
26-Nov-2022
Additional information
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Spain
Co-Evaluating Member State
Initial grounds for concern
Suspected Reprotoxic
Potential endocrine disruptor
Year
2019
Status
Concluded
Conclusion document
Latest update
24-Aug-2020
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
Spain
Status
Concluded
Outcome
postponed
Hazard assessment outcome document
Remarks
Postponed because the ED concern related to potential human exposure has not been clarified under SEv. If in future new uses are identified under REACH, or there are new registrants of this substance, authorities shall consider including the substance again in the CoRAP for obtaining the information which is considered important/necessary to clarify the remaining ED concern related to potential human exposure
Concern
Endocrine disruption
Date of intention
14-Oct-2019
Date of hazard assessment
Latest update
23-Jan-2023
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Opinion Adopted
Date of intention
24-Aug-2020
Withdrawal date
Submitter
Spain
Proposed harmonised classification by the dossier submitter
Repr. 1B, H360FD
STOT SE 3, H335
STOT SE 3, H336
Remarks
Date of opinion
14-Sep-2023
RAC Opinion
Latest update
23-Nov-2023
More information View

List entry date: 12-Nov-2018

Export search results to: